ID   CALX_CANLF              Reviewed;         593 AA.
AC   P24643; P79140;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=Calnexin;
DE   AltName: Full=pp90;
DE   Flags: Precursor;
GN   Name=CANX;
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1918067; DOI=10.1016/s0021-9258(18)55036-5;
RA   Wada I., Rindress D., Cameron P.H., Ou W.-J., Doherty J.J. II, Louvard D.,
RA   Bell A.W., Dignard D., Thomas D.Y., Bergeron J.J.M.;
RT   "SSR alpha and associated calnexin are major calcium binding proteins of
RT   the endoplasmic reticulum membrane.";
RL   J. Biol. Chem. 266:19599-19610(1991).
RN   [2]
RP   SEQUENCE REVISION TO 67.
RA   Dignard D.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH PPIB, AND MUTAGENESIS OF ASP-348.
RX   PubMed=20801878; DOI=10.1074/jbc.m110.160101;
RA   Kozlov G., Bastos-Aristizabal S., Maattanen P., Rosenauer A., Zheng F.,
RA   Killikelly A., Trempe J.F., Thomas D.Y., Gehring K.;
RT   "Structural basis of cyclophilin B binding by the calnexin/calreticulin P-
RT   domain.";
RL   J. Biol. Chem. 285:35551-35557(2010).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 45-468 IN COMPLEX WITH CALCIUM,
RP   DISULFIDE BONDS, AND PROBABLE CARBOHYDRATE-INTERACTING SITES.
RX   PubMed=11583625; DOI=10.1016/s1097-2765(01)00318-5;
RA   Schrag J.D., Bergeron J.J., Li Y., Borisova S., Hahn M., Thomas D.Y.,
RA   Cygler M.;
RT   "The Structure of calnexin, an ER chaperone involved in quality control of
RT   protein folding.";
RL   Mol. Cell 8:633-644(2001).
CC   -!- FUNCTION: Calcium-binding protein that interacts with newly synthesized
CC       monoglucosylated glycoproteins in the endoplasmic reticulum. It may act
CC       in assisting protein assembly and/or in the retention within the ER of
CC       unassembled protein subunits. It seems to play a major role in the
CC       quality control apparatus of the ER by the retention of incorrectly
CC       folded proteins. Associated with partial T-cell antigen receptor
CC       complexes that escape the ER of immature thymocytes, it may function as
CC       a signaling complex regulating thymocyte maturation. Additionally it
CC       may play a role in receptor-mediated endocytosis at the synapse (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MAPK3/ERK1 (By similarity). Interacts with
CC       KCNH2 (By similarity). Associates with ribosomes (By similarity).
CC       Interacts with SGIP1; involved in negative regulation of endocytosis
CC       (By similarity). The palmitoylated form interacts with the ribosome-
CC       translocon complex component SSR1, promoting efficient folding of
CC       glycoproteins (By similarity). Interacts with SERPINA2P/SERPINA2 and
CC       with the S and Z variants of SERPINA1 (By similarity). Interacts with
CC       PPIB (PubMed:20801878). Interacts with ZNRF4 (By similarity). Interacts
CC       with SMIM22 (By similarity). Interacts with TMX2 (By similarity).
CC       Interacts with TMEM35A/NACHO and CHRNA7 (By similarity).
CC       {ECO:0000250|UniProtKB:P27824, ECO:0000250|UniProtKB:P35564,
CC       ECO:0000250|UniProtKB:P35565, ECO:0000269|PubMed:20801878}.
CC   -!- INTERACTION:
CC       P24643; P30101: PDIA3; Xeno; NbExp=3; IntAct=EBI-15596385, EBI-979862;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P27824}; Single-pass type I membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P27824}.
CC       Melanosome {ECO:0000250|UniProtKB:P27824}. Note=The palmitoylated form
CC       preferentially localizes to the perinuclear rough ER.
CC       {ECO:0000250|UniProtKB:P27824}.
CC   -!- PTM: Phosphorylated at Ser-565 by MAPK3/ERK1. phosphorylation by
CC       MAPK3/ERK1 increases its association with ribosomes (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Palmitoylation by DHHC6 leads to the preferential localization to
CC       the perinuclear rough ER. It mediates the association of calnexin with
CC       the ribosome-translocon complex (RTC) which is required for efficient
CC       folding of glycosylated proteins (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation. Probably
CC       ubiquitinated by ZNRF4. {ECO:0000250|UniProtKB:P27824}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X53616; CAA37678.1; -; mRNA.
DR   PIR; A37273; A37273.
DR   RefSeq; NP_001003232.1; NM_001003232.1.
DR   PDB; 1JHN; X-ray; 2.90 A; A=45-468.
DR   PDBsum; 1JHN; -.
DR   AlphaFoldDB; P24643; -.
DR   SMR; P24643; -.
DR   BioGRID; 139826; 1.
DR   DIP; DIP-29133N; -.
DR   IntAct; P24643; 1.
DR   STRING; 9612.ENSCAFP00000042695; -.
DR   UniLectin; P24643; -.
DR   iPTMnet; P24643; -.
DR   SwissPalm; P24643; -.
DR   PaxDb; P24643; -.
DR   PRIDE; P24643; -.
DR   GeneID; 403908; -.
DR   KEGG; cfa:403908; -.
DR   CTD; 821; -.
DR   eggNOG; KOG0675; Eukaryota.
DR   InParanoid; P24643; -.
DR   OrthoDB; 775337at2759; -.
DR   EvolutionaryTrace; P24643; -.
DR   Proteomes; UP000002254; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:AgBase.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISS:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   Gene3D; 2.10.250.10; -; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073; PTHR11073; 1.
DR   Pfam; PF00262; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF63887; SSF63887; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
DR   PROSITE; PS00805; CALRETICULIN_REPEAT; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Chaperone; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; Lectin; Lipoprotein; Membrane;
KW   Metal-binding; Palmitate; Phosphoprotein; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..20
FT   CHAIN           21..593
FT                   /note="Calnexin"
FT                   /id="PRO_0000004197"
FT   TOPO_DOM        21..482
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        483..503
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        504..593
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          279..290
FT                   /note="1-1"
FT   REPEAT          296..307
FT                   /note="1-2"
FT   REPEAT          315..326
FT                   /note="1-3"
FT   REPEAT          334..345
FT                   /note="1-4"
FT   REPEAT          349..359
FT                   /note="2-1"
FT   REPEAT          368..378
FT                   /note="2-2"
FT   REPEAT          382..392
FT                   /note="2-3"
FT   REPEAT          396..406
FT                   /note="2-4"
FT   REGION          261..346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          277..410
FT                   /note="P domain (Extended arm)"
FT   REGION          279..345
FT                   /note="4 X approximate repeats"
FT   REGION          327..360
FT                   /note="Interaction with PPIB"
FT                   /evidence="ECO:0000269|PubMed:20801878"
FT   REGION          349..406
FT                   /note="4 X approximate repeats"
FT   REGION          504..593
FT                   /note="Sufficient to mediate interaction with SGIP1"
FT                   /evidence="ECO:0000250"
FT   REGION          511..593
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..327
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..346
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        526..547
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        548..586
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         75
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         118
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         165
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211,
FT                   ECO:0000305|PubMed:11583625"
FT   BINDING         167
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211,
FT                   ECO:0000305|PubMed:11583625"
FT   BINDING         186
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211,
FT                   ECO:0000305|PubMed:11583625"
FT   BINDING         193
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         426
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211,
FT                   ECO:0000305|PubMed:11583625"
FT   BINDING         437
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   MOD_RES         138
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         555
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         563
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         565
FT                   /note="Phosphoserine; by MAPK3"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         584
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   LIPID           503
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           504
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        161..195
FT                   /evidence="ECO:0000269|PubMed:11583625"
FT   DISULFID        361..367
FT                   /evidence="ECO:0000269|PubMed:11583625"
FT   MUTAGEN         348
FT                   /note="D->K: Abolishes interaction with PPIB."
FT                   /evidence="ECO:0000269|PubMed:20801878"
FT   STRAND          71..74
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          131..140
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          142..145
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          147..153
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          160..163
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          166..170
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          186..197
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          200..208
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   TURN            210..212
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          215..218
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   HELIX           229..232
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          237..244
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   TURN            245..247
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          248..253
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          256..261
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          292..295
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          325..328
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   TURN            345..347
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   HELIX           359..361
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          367..369
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          374..376
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          388..390
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          420..425
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          430..432
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   STRAND          437..445
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   HELIX           446..454
FT                   /evidence="ECO:0007829|PDB:1JHN"
FT   TURN            455..457
FT                   /evidence="ECO:0007829|PDB:1JHN"
SQ   SEQUENCE   593 AA;  67603 MW;  A2969701B1EB7B6A CRC64;
     MEGKWLLCML LVLGTTIVQA HEGHDDDMID IEDDLDDVIE EVEDSKSKPD TSAPTSPKVT
     YKAPVPTGEV YFADSFDRGT LSGWILSKAK KDDTDDEIAK YDGKWEVDEM KETKLPGDKG
     LVLMSRAKHH AISAKLNKPF LFDTKPLIVQ YEVNFQNGIE CGGAYVKLLS KTPELNLDQF
     HDKTPYTIMF GPDKCGEDYK LHFIFRHKNP KTGVYEEKHA KRPDADLKTY FTDKKTHLYT
     LILNPDNSFE ILVDQSIVNS GNLLNDMTPP VNPSREIEDP EDQKPEDWDE RPKIPDPDAV
     KPDDWNEDAP AKIPDEEATK PDGWLDDEPE YVPDPDAEKP EDWDEDMDGE WEAPQIANPK
     CESAPGCGVW QRPMIDNPNY KGKWKPPMID NPNYQGIWKP RKIPNPDFFE DLEPFKMTPF
     SAIGLELWSM TSDIFFDNFI VCGDRRVVDD WANDGWGLKK AADGAAEPGV VGQMIEAAEE
     RPWLWVVYVL TVALPVFLVI LFCCSGKKQS SPVEYKKTDA PQPDVKEEEE EKEEEKDKGD
     EEEEGEEKLE EKQKSDAEED GGTASQEEDD RKPKAEEDEI LNRSPRNRKP RRE
//
